StonvexLoading…
StonvexCore line items from RDNW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $326.13M | $260.40M | $1.08B | $825.60M | $544.60M |
Operating Income | Not available | $7.60M | $-200.00K | $-5.60M | $-15.00M |
Net Income | Not available | $-4.30M | $-52.40M | $-46.00M | $-41.90M |
EPS (Diluted) | $0.13 | $-0.11 | $-1.38 | $-1.21 | $-1.11 |
Total Assets | Not available | $721.70M | $673.60M | $699.40M | $712.30M |
Total Liabilities | Not available | $737.90M | $686.10M | $706.30M | $717.00M |
Cash & Equivalents | Not available | $30.20M | $29.50M | $35.40M | $44.70M |
Free Cash Flow OCF − CapEx | Not available | $-28.20M | $10.30M | $10.50M | $1.10M |
Shares Outstanding | Not available | 38.41M | 37.96M | 37.92M | 37.85M |